{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:37:08Z","timestamp":1787017028219,"version":"build-2736575974"},"reference-count":39,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,2,18]]},"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Patients\u2019 first-hand experiences of faecal microbiota transplantation (FMT) performed in a rheumatological care setting have yet to be elucidated. The objectives were to explore participants\u2019 perceptions of being part of an FMT trial thereby identifying potential trial participation effects and enlightening the patient perspective on the outlook for future FMT trials in rheumatic diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>In a qualitative study nested within a double-blind, randomised, placebo-controlled trial (RCT) testing FMT as a potential new antirheumatic treatment, semistructured telephone interviews were conducted following the trial participants\u2019 final 26-week visit. Qualitative researchers, who did not take part in the main trial, performed the interviews and the primary analysis. The experiences explored related to the conduct of the RCT and changes in the participants\u2019 everyday life. The analysis was carried out using a thematic approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>A Danish rheumatology university outpatient clinic with nationwide inclusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>The study included 10 patients with psoriatic arthritis (PsA) who were unaware of their treatment allocation (FMT\/sham transplantation) and completed the final 26-week trial visit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Participation in the RCT influenced the patients\u2019 understanding of PsA and induced positive changes in their everyday life. Renewed hopes for the future in addition to a feeling of enhanced care contributed to significant trial participation effects. FMT was deemed a tolerable and safe treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Discrepancies between the clinical and the research setting should be considered when discussing the clinical relevance of the results of the RCT. Overall, patients with PsA who have participated in an RCT testing FMT find the treatment acceptable and safe encouraging more research into the field of microbiota-targeted interventions in rheumatic diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial pre-results\" xlink:href=\"NCT03058900\">NCT03058900<\/jats:ext-link>\n                      ; Pre-results.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-039471","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T11:05:59Z","timestamp":1615201559000},"page":"e039471","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":20,"title":["Experiences and perceptions of patients with psoriatic arthritis participating in a trial of faecal microbiota transplantation: a nested qualitative study"],"prefix":"10.1136","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct03058900","registry":"10.18810\/clinical-trials-gov","type":"preResults"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9641-9065","authenticated-orcid":false,"given":"Maja Skov","family":"Kragsnaes","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5854-2142","authenticated-orcid":false,"given":"Shaun Theodor","family":"S\u00f8dergren","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Odense University Hospital, Odense, Denmark"},{"name":"National Institute of Public Health, University of Southern Denmark, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8148-6572","authenticated-orcid":false,"given":"Jens","family":"Kjeldsen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Christian","family":"Horn","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi Lausten","family":"Munk","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Kristian","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Svendborg Hospital, Odense University Hospital, Svendborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla Schufri","family":"Klinkby","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8428-6354","authenticated-orcid":false,"given":"Maarten","family":"de Wit","sequence":"additional","affiliation":[{"name":"Patient Research Partner, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0539-2061","authenticated-orcid":false,"given":"Nanna Gram","family":"Ahlmark","sequence":"additional","affiliation":[{"name":"National Institute of Public Health, University of Southern Denmark, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine","family":"Tj\u00f8rnh\u00f8j-Thomsen","sequence":"additional","affiliation":[{"name":"National Institute of Public Health, University of Southern Denmark, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0426-4962","authenticated-orcid":false,"given":"Torkell","family":"Ellingsen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,3,8]]},"reference":[{"key":"2025121403205562000_11.3.e039471.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1505557"},{"key":"2025121403205562000_11.3.e039471.2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208337"},{"key":"2025121403205562000_11.3.e039471.3","doi-asserted-by":"crossref","first-page":"kew390","DOI":"10.1093\/rheumatology\/kew390","article-title":"New grappa and EULAR recommendations for the management of psoriatic arthritis","volume":"56","author":"Coates","year":"2017","journal-title":"Rheumatology"},{"key":"2025121403205562000_11.3.e039471.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30830-4"},{"key":"2025121403205562000_11.3.e039471.5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39259","article-title":"Microbiome in inflammatory arthritis and human rheumatic diseases","volume":"68","author":"Scher","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025121403205562000_11.3.e039471.6","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1177\/2050640619867555","article-title":"Gut microbiome in chronic rheumatic and inflammatory bowel diseases: similarities and differences","volume":"7","author":"Salem","year":"2019","journal-title":"United European Gastroenterol J"},{"key":"2025121403205562000_11.3.e039471.7","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nrrheum.2016.85","article-title":"How the microbiota shapes rheumatic diseases","volume":"12","author":"Van de Wiele","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"2025121403205562000_11.3.e039471.8","first-page":"30","article-title":"Fecal microbiota transplantation: donor relation, fresh or frozen, delivery methods, cost-effectiveness","volume":"32","author":"Ramai","year":"2019","journal-title":"Ann Gastroenterol"},{"key":"2025121403205562000_11.3.e039471.9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019231"},{"key":"2025121403205562000_11.3.e039471.10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b3496"},{"key":"2025121403205562000_11.3.e039471.11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a288"},{"key":"2025121403205562000_11.3.e039471.12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002889","article-title":"What can qualitative research do for randomised controlled trials? A systematic mapping review","volume":"3","author":"O'Cathain","year":"2013","journal-title":"BMJ Open"},{"key":"2025121403205562000_11.3.e039471.13","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042"},{"key":"2025121403205562000_11.3.e039471.14","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0000000000000388"},{"key":"2025121403205562000_11.3.e039471.15","unstructured":"Boyatzis RE . Transforming qualitative data: thematic analysis and code development. Thousand Oaks, California: SAGE publication, 1998."},{"key":"2025121403205562000_11.3.e039471.16","unstructured":"Cornish F , Gillespie A , Zittoun T . Handbook of qualitative data analysis. Thousand Oaks, California: SAGE publication, 2013."},{"key":"2025121403205562000_11.3.e039471.17","doi-asserted-by":"publisher","DOI":"10.1111\/1467-9566.ep11339939"},{"key":"2025121403205562000_11.3.e039471.18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/bs.irn.2020.04.002","article-title":"Strategies to minimize placebo effects in research investigations","volume":"153","author":"Rodrigues","year":"2020","journal-title":"Int Rev Neurobiol"},{"key":"2025121403205562000_11.3.e039471.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2014.03.002"},{"key":"2025121403205562000_11.3.e039471.20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.irn.2018.07.010","article-title":"Placebo effects: historical and modern evaluation","volume":"139","author":"Finniss","year":"2018","journal-title":"Int Rev Neurobiol"},{"key":"2025121403205562000_11.3.e039471.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1907805"},{"key":"2025121403205562000_11.3.e039471.22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41584-018-0110-9","article-title":"Nocebos in rheumatology: emerging concepts and their implications for clinical practice","volume":"14","author":"Kravvariti","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2025121403205562000_11.3.e039471.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.08.015"},{"key":"2025121403205562000_11.3.e039471.24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039116"},{"key":"2025121403205562000_11.3.e039471.25","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216137"},{"key":"2025121403205562000_11.3.e039471.26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h4672"},{"key":"2025121403205562000_11.3.e039471.27","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.181185"},{"key":"2025121403205562000_11.3.e039471.28","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis809"},{"key":"2025121403205562000_11.3.e039471.29","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21775"},{"key":"2025121403205562000_11.3.e039471.30","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e318281f520"},{"key":"2025121403205562000_11.3.e039471.31","unstructured":"DasMahapatra P , Raja P , Gilbert J . Clinical trials from the patient perspective: survey in an online patient community. BMC Health Serv Res;27:166."},{"key":"2025121403205562000_11.3.e039471.32","doi-asserted-by":"crossref","DOI":"10.1186\/s12904-020-00661-7","article-title":"Nothing to lose: a grounded theory study of patients' and healthcare professionals' perspectives of being involved in the consent process for oncology trials with non-curative intent","volume":"19","author":"Murphy","year":"2020","journal-title":"BMC Palliat Care"},{"key":"2025121403205562000_11.3.e039471.33","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ajic.2016.01.018","article-title":"Fecal microbiota transplantation for recurrent Clostridium difficile infection: the patient experience","volume":"44","author":"Pakyz","year":"2016","journal-title":"Am J Infect Control"},{"key":"2025121403205562000_11.3.e039471.34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1155\/2014\/403828","article-title":"Physician attitudes toward the use of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection","volume":"28","author":"Zipursky","year":"2014","journal-title":"Can J Gastroenterol Hepatol"},{"key":"2025121403205562000_11.3.e039471.35","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-019-3633-8","article-title":"Hope and despair: a qualitative exploration of the experiences and impact of trial processes in a rehabilitation trial","volume":"20","author":"Norris","year":"2019","journal-title":"Trials"},{"key":"2025121403205562000_11.3.e039471.36","unstructured":"Brinkmann S , Steinar K . Interviews: learning the craft of qualitative interviewing. Thousand Oaks: Sage Publications, 2015."},{"key":"2025121403205562000_11.3.e039471.37","first-page":"4","article-title":"Advantages and disadvantages of four interview techniques in qualitative research","volume":"7","author":"Opdenakker","year":"2006","journal-title":"Forum Qualitative Sozialforschung\/Forum: Qualitative Social Research"},{"key":"2025121403205562000_11.3.e039471.38","doi-asserted-by":"publisher","DOI":"10.1177\/1468794112439005"},{"key":"2025121403205562000_11.3.e039471.39","doi-asserted-by":"publisher","DOI":"10.1177\/1468794104041110"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-039471","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T11:21:04Z","timestamp":1765711264000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-039471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,8]]},"published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1136\/bmjopen-2020-039471"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-039471","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}